Clinical Trial

PVP-Guided Decongestive Therapy in HF 2

Study acronym: PERIPHERAL-HF2
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2024 (before its estimated July 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2024-07-03; most recent amendment 2024-12-01.
Status change: Not Yet Recruiting → Recruiting 2024-07-14
Trial Details
NCT Number NCT06495892
Lead Sponsor Başakşehir Çam & Sakura City Hospital
Collaborators: Ankara Etlik City Hospital, Akdeniz University, Bağcılar Training and Research Hospital, Bakırçay University, Faculty of Medicine, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Eskişehir City Hospital, İdil State Hospital, Kafkas University Health Research and Application Hospital, Kutahya Health Sciences University, Istanbul Mehmet Akif Ersoy Educational and Training Hospital, Pazarcık State Hospital, Tokat Gaziosmanpasa University, Trakya University, Ataturk University
Conditions Heart Failure, Congestion, Congestive Heart Failure
Enrollment 650 participants
Start Date 2024-07-01
Primary Completion 2025-07-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-04